QIM
NWBO

Quantitative Investment Management’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Quantitative Investment Management’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-116,900
Closed -$67K – 1005
2016
Q2 		$67K Buy
116,900
+74,200
+174% +$79.2K ﹤0.01% 709
2016
Q1 		$62K Buy
42,700
+19,700
+86% +$38.9K ﹤0.01% 735
2015
Q4 		$73K Buy
23,000
+800
+4% +$3.85K ﹤0.01% 668
2015
Q3 		$138K Buy
22,200
+8,600
+63% +$80.4K 0.01% 629
2015
Q2 		$135K Buy
+13,600
New +$119K 0.02% 406
2014
Q3 		– Sell
-19,800
Closed -$132K – 633
2014
Q2 		$132K Sell
19,800
-300
-1% -$1.91K 0.02% 422
2014
Q1 		$145K Buy
+20,100
New +$119K 0.01% 496

Other funds holding NWBO

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CDH
Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quantitative Investment Management's NWBO Position: Q3 2016 in Review

Quantitative Investment Management sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q3 2016, closing a stake of 116,900 shares — an estimated $67K sold.

Quantitative Investment Management first reported a position in NWBO in Q1 2014 and held it in 7 quarters. The position peaked at $145K in Q1 2014. 54 funds tracked by Wall St. Rank hold NWBO as of Q3 2016.

  • Quantitative Investment Management reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q3 2016 after selling out during the quarter.
  • Quantitative Investment Management sold 116,900 Northwest Biotherapeutics, Inc. Common stock shares in Q3 2016, an estimated $67K.
  • Quantitative Investment Management first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q1 2014 and held it in 7 quarters.
  • Quantitative Investment Management's Northwest Biotherapeutics, Inc. Common stock position peaked at $145K in Q1 2014.
  • 54 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q3 2016.

Based on Quantitative Investment Management's 13F filing for Q3 2016, filed 1 Nov 2016.